Free Trial

NLS Pharmaceutics (NLSP) Short Interest Ratio & Short Volume

NLS Pharmaceutics logo
$3.60
-0.03 (-0.83%)
(As of 11/1/2024 ET)

NLS Pharmaceutics Short Interest Data

NLS Pharmaceutics (NLSP) has a short interest of 51,800 shares, representing 2.88% of the float (the number of shares available for trading by the public). This marks a 29.18% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 100,509 shares to cover all short positions.

Current Short Interest
51,800 shares
Previous Short Interest
40,100 shares
Change Vs. Previous Month
+29.18%
Dollar Volume Sold Short
$247,086.00
Short Interest Ratio
0.7 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
3,820,000 shares
Float Size
1,800,000 shares
Short Percent of Float
2.88%
Today's Trading Volume
10,793 shares
Average Trading Volume
100,509 shares
Today's Volume Vs. Average
11%
Short Selling NLS Pharmaceutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for NLS Pharmaceutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NLSP Short Interest Over Time

NLSP Days to Cover Over Time

NLSP Percentage of Float Shorted Over Time

NLS Pharmaceutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202451,800 shares $247,086.00 +29.2%2.9%0.7 $4.77
9/30/202440,100 shares $203,307.00 -96.8%5.3%0.6 $5.07
9/15/20241,250,000 shares $169,000.00 +5.0%4.2%0.2 $0.14
8/31/20241,190,000 shares $177,429.00 -25.6%4.0%0.1 $0.15
8/15/20241,600,000 shares $273,920.00 -58.2%5.4%0.1 $0.17
7/31/20243,830,000 shares $840,302.00 +602.9%13.4%0.3 $0.22
7/15/2024544,900 shares $111,704.50 -89.5%1.9%0.1 $0.21
6/30/20245,170,000 shares $1.12 million +2,335.2%18.1%0.5 $0.22
6/15/2024212,300 shares $24,185.64 -43.4%0.8%0 $0.11
5/31/2024375,200 shares $52,903.20 +726.4%1.4%0.4 $0.14
5/15/202445,400 shares $6,628.40 +182.0%0.2%0.1 $0.15
4/30/202416,100 shares $2,249.17 -78.6%0.1%0 $0.14
4/15/202475,100 shares $10,626.65 -77.6%0.3%0.1 $0.14
3/31/2024335,800 shares $60,444.00 +854.0%1.5%0.6 $0.18
3/15/202435,200 shares $10,876.80 -43.0%0.2%0.1 $0.31
2/29/202461,800 shares $23,904.24 -22.4%0.3%0.8 $0.39
2/15/202479,600 shares $35,820.00 -15.4%0.3%0.2 $0.45
1/31/202494,100 shares $43,286.00 -22.4%0.4%0.2 $0.46
1/15/2024121,200 shares $63,024.00 -19.7%0.5%0.2 $0.52
12/31/2023150,900 shares $89,015.91 +32.5%0.7%0.3 $0.59
12/15/2023113,900 shares $54,672.00 -15.0%0.5%0.2 $0.48
11/30/2023134,000 shares $58,785.80 +29.0%0.7%0.2 $0.44
11/15/2023103,900 shares $50,713.59 -37.2%0.5%0.7 $0.49
10/31/2023165,400 shares $109,164.00 -24.0%0.8%1.6 $0.66
10/15/2023217,700 shares $182,693.84 +40.2%1.1%1.8 $0.84
9/30/2023155,300 shares $108,710.00 -2.1%0.8%1.7 $0.70
9/15/2023158,600 shares $131,526.98 +33.3%0.8%0.9 $0.83
8/31/2023119,000 shares $121,380.00 +38.7%0.6%0.7 $1.02
8/15/202385,800 shares $70,347.42 -23.5%0.4%0.6 $0.82
7/31/2023112,100 shares $104,006.38 +95.3%0.6%0.8 $0.93
7/15/202357,400 shares $51,591.12 +48.7%0.3%0.5 $0.90
6/30/202338,600 shares $42,460.00 -43.4%0.2%0.3 $1.10
6/15/202368,200 shares $66,154.00 -31.7%0.3%1.6 $0.97
5/31/202399,900 shares $102,897.00 -8.9%0.5%2.4 $1.03
5/15/2023109,600 shares $117,820.00 -6.4%0.5%2.2 $1.08
4/30/2023117,100 shares $155,743.00 -0.4%0.5%2.3 $1.33
4/15/2023117,600 shares $183,456.00 -7.2%0.6%2.3 $1.56
3/31/2023126,700 shares $192,584.00 +44.3%0.6%1.8 $1.52
3/15/202387,800 shares $130,822.00 -38.8%0.4%1 $1.49
2/28/2023143,500 shares $205,205.00 +5.6%0.7%1.5 $1.43
Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).
2/15/2023135,900 shares $186,183.00 +13.4%0.7%1.1 $1.37
1/31/2023119,800 shares $155,740.00 -22.3%0.6%0.8 $1.30
1/15/2023154,100 shares $265,052.00 -23.2%0.7%0.4 $1.72
12/30/2022200,700 shares $258,903.00 +32.2%0.9%0.5 $1.29
12/15/2022151,800 shares $157,872.00 +26.6%0.7%0.3 $1.04
11/30/2022119,900 shares $99,517.00 -23.3%1.0%0.2 $0.83
11/15/2022156,300 shares $78,915.87 +63.0%1.3%0.3 $0.50
10/31/202295,900 shares $50,107.75 +15.7%0.8%0.1 $0.52
10/15/202282,900 shares $43,108.00 -57.2%0.7%0.2 $0.52
9/30/2022193,500 shares $119,970.00 -27.6%1.4%0.4 $0.62
9/15/2022267,100 shares $226,500.80 +80.6%1.9%0.6 $0.85
8/31/2022147,900 shares $73,195.71 -27.5%1.1%0.4 $0.49
8/15/2022203,900 shares $100,930.50 -6.0%1.5%0.6 $0.50
7/31/2022216,900 shares $80,209.62 +111.8%1.6%0.8 $0.37
7/15/2022102,400 shares $65,382.40 -28.3%0.8%0.5 $0.64
6/30/2022142,800 shares $83,852.16 +35.4%1.1%2.4 $0.59
6/15/2022105,500 shares $62,034.00 -21.6%0.8%1.9 $0.59
5/31/2022134,500 shares $91,460.00 +40.8%1.0%1.4 $0.68
5/15/202295,500 shares $55,390.00 -13.7%0.7%0.8 $0.58
4/30/2022110,600 shares $94,795.26 -6.2%0.9%0.7 $0.86
4/15/2022117,900 shares $122,616.00 -26.1%1.0%0.7 $1.04
3/31/2022159,600 shares $225,036.00 +39.3%2.0%0.6 $1.41
3/15/2022114,600 shares $201,696.00 -19.9%1.4%0 $1.76
2/28/2022143,100 shares $170,289.00 +246.5%1.8%0 $1.19
2/15/202241,300 shares $44,191.00 -6.1%0.7%0 $1.07
1/31/202244,000 shares $39,600.00 -85.6%0.7%0 $0.90
1/15/2022305,300 shares $332,777.00 +172.6%5.1%0.1 $1.09
12/31/2021112,000 shares $124,320.00 -17.3%1.9%0 $1.11
12/15/2021135,400 shares $167,706.44 +56.7%2.3%0.2 $1.24
11/30/202186,400 shares $175,392.00 +8.3%1.4%0.1 $2.03
11/15/202179,800 shares $173,166.00 -13.8%1.3%1.2 $2.17
10/29/202192,600 shares $200,016.00 +51.6%1.5%0.3 $2.16
10/15/202161,100 shares $147,251.00 +25.0%1.0%0.2 $2.41
9/30/202148,900 shares $122,250.00 -55.2%0.8%0.1 $2.50
9/15/2021109,200 shares $287,196.00 -19.5%1.9%0.2 $2.63
8/31/2021135,600 shares $334,932.00 +227.5%2.4%0.3 $2.47
8/13/202141,400 shares $97,704.00 No Change0.7%0.1 $2.36

NLSP Short Interest - Frequently Asked Questions

What is NLS Pharmaceutics' current short interest?

Short interest is the volume of NLS Pharmaceutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 51,800 shares of NLSP short. 2.88% of NLS Pharmaceutics' shares are currently sold short. Learn More on NLS Pharmaceutics' current short interest.

What is a good short interest ratio for NLS Pharmaceutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NLSP shares currently have a short interest ratio of 1.0. Learn More on NLS Pharmaceutics's short interest ratio.

What is a good short interest percentage for NLS Pharmaceutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.88% of NLS Pharmaceutics' floating shares are currently sold short.

Is NLS Pharmaceutics' short interest increasing or decreasing?

NLS Pharmaceutics saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 51,800 shares, an increase of 29.2% from the previous total of 40,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is NLS Pharmaceutics' float size?

NLS Pharmaceutics currently has issued a total of 3,820,000 shares. Some of NLS Pharmaceutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NLS Pharmaceutics currently has a public float of 1,800,000 shares.

How does NLS Pharmaceutics' short interest compare to its competitors?

2.88% of NLS Pharmaceutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NLS Pharmaceutics: Mural Oncology plc (2.50%), Cidara Therapeutics, Inc. (1.09%), Reneo Pharmaceuticals, Inc. (15.65%), Kronos Bio, Inc. (1.71%), Precision BioSciences, Inc. (5.77%), Immuneering Co. (7.24%), Barinthus Biotherapeutics plc (0.01%), Monopar Therapeutics Inc. (2.84%), Theratechnologies Inc. (0.18%), Actinium Pharmaceuticals, Inc. (7.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short NLS Pharmaceutics stock?

Short selling NLSP is an investing strategy that aims to generate trading profit from NLS Pharmaceutics as its price is falling. NLSP shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NLS Pharmaceutics?

A short squeeze for NLS Pharmaceutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NLSP, which in turn drives the price of the stock up even further.

How often is NLS Pharmaceutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NLSP, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:NLSP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners